US 6613757
COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY
expired A61KA61K31/565A61K31/566
Quick answer
US patent 6613757 (COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY) held by The Board of Regents of the University of Texas System expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/565, A61K31/566, A61K31/567, A61K31/57